ATE160288T1 - Antikörper, ihre herstellung und verwendung - Google Patents

Antikörper, ihre herstellung und verwendung

Info

Publication number
ATE160288T1
ATE160288T1 AT90116234T AT90116234T ATE160288T1 AT E160288 T1 ATE160288 T1 AT E160288T1 AT 90116234 T AT90116234 T AT 90116234T AT 90116234 T AT90116234 T AT 90116234T AT E160288 T1 ATE160288 T1 AT E160288T1
Authority
AT
Austria
Prior art keywords
polypeptide
antibody
formula
acid sequence
producing
Prior art date
Application number
AT90116234T
Other languages
English (en)
Inventor
Kazuo Nakahama
Tsunehiko Fukuda
Tsutomu Kurokawa
Ken-Ichi Kuroshima
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE160288T1 publication Critical patent/ATE160288T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C07K14/625—Extraction from natural sources
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90116234T 1989-08-28 1990-08-24 Antikörper, ihre herstellung und verwendung ATE160288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21871189 1989-08-28
JP13405890 1990-05-25

Publications (1)

Publication Number Publication Date
ATE160288T1 true ATE160288T1 (de) 1997-12-15

Family

ID=26468244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90116234T ATE160288T1 (de) 1989-08-28 1990-08-24 Antikörper, ihre herstellung und verwendung

Country Status (7)

Country Link
EP (1) EP0418590B1 (de)
AT (1) ATE160288T1 (de)
CA (1) CA2024063C (de)
DE (1) DE69031726T2 (de)
DK (1) DK0418590T3 (de)
ES (1) ES2109225T3 (de)
GR (1) GR3025835T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
US7255860B2 (en) 2002-10-08 2007-08-14 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
ZA200502612B (en) 2002-10-08 2007-07-25 Rinat Neuroscience Corp Methods for treating post-surgical pain by administering a nerve crowth factor antagonist and compositions containing the same
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
CN101014364B (zh) 2002-12-24 2012-01-18 里纳特神经系统学公司 抗ngf抗体及其使用方法
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
EP2191846A1 (de) 2003-02-19 2010-06-02 Rinat Neuroscience Corp. Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor-antagonisten und eines nsaid und diese enthaltende zusammensetzung
CN102408483B (zh) 2003-07-15 2016-06-08 安姆根有限公司 作为选择性ngf途径抑制剂的人抗ngf中和抗体
JP5301152B2 (ja) 2004-04-07 2013-09-25 ライナット ニューロサイエンス コーポレイション 神経成長因子アンタゴニストを投与することによって骨癌の疼痛を処置するための方法
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
US20110300068A1 (en) 2009-01-12 2011-12-08 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of cancer

Also Published As

Publication number Publication date
JPH04128298A (ja) 1992-04-28
EP0418590A1 (de) 1991-03-27
DE69031726D1 (de) 1998-01-02
CA2024063C (en) 2002-07-16
DK0418590T3 (da) 1998-04-20
EP0418590B1 (de) 1997-11-19
ES2109225T3 (es) 1998-01-16
DE69031726T2 (de) 1998-03-12
CA2024063A1 (en) 1991-03-01
GR3025835T3 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
US4636463A (en) Antibodies to human interleukin-2 induced by synthetic polypeptides
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
LU91013I2 (fr) ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base
ATE155141T1 (de) Glykosphingolipide mit kopplungsfähiger gruppe im sphingoidanteil, ihre herstellung und verwendung
DE60039596D1 (de) Verfahren zur herstellung von monoklonalen antikörpern
DE69031726D1 (de) Antikörper, ihre Herstellung und Verwendung
AU564620B2 (en) Peptides and protein-peptide complexes
DE68927459D1 (de) Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
BG101408A (bg) Аналози на кератиноцитния растежен фактор
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
EP0180921A3 (de) Verfahren zur Herstellung und Reinigung von Peptiden
EP0741869A1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO900758L (no) Fremgangsmaate for fremstilling av hybridprotein.
ATE221082T1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä- b zellen und sein gen
NO871573D0 (no) Fremgangsmaate for fremstilling av peptider.
DE3781832D1 (de) C-terminal-alpha-amidierendes enzym und verfahren zu dessen herstellung und verwendung.
DK0404750T3 (da) Vævsinhibitor for metalloproteaser
ATE99360T1 (de) Monoklonale antikoerper, die atriales natriuretisches polypeptide erkennen, ihre herstellung und verwendung.
Yanaihara et al. Synthesis of proinsulin. III. Synthesis of polypeptides related to the connecting peptide segment of bovine proinsulin
NO904129D0 (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.

Legal Events

Date Code Title Description
EEFA Change of the company name
EEFA Change of the company name
EELA Cancelled due to lapse of time